Back to search
FDAFDA · Food and drugs·Recall number D-1378-2020

Nystatin Oral Suspension, USP 100,000 units per mL, Bubblegum Flavored, 16 fl. oz. bottle (480 mL), Shake Well Before Using, Rx Only, Manufactured by: VistaPharm, Inc., Largo, FL 33771, NDC 66689-008-16.

Published July 15, 2020 · Recall initiated: June 23, 2020

Summary

FDA records drug Class III recall D-1378-2020, published July 15, 2020 and initiated June 23, 2020. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 14,760 bottles; Lot: Lot # 639000, Exp. 10/31/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
VistaPharm, Inc.
Distributor
United States including Puerto Rico
Lot
Lot # 639000, Exp. 10/31/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP 100,000 units per mL, Bubblegum Flavored, 16 fl. oz. bottle (480 mL), Shake Well Before Using, Rx Only, Manufactured by: VistaPharm, Inc., Largo, FL 33771, NDC 66689-008-16. recalled?

Yes. FDA published recall D-1378-2020 on July 15, 2020. Reported hazard: Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

What should I do if I have this product?

Voluntary: Firm initiated · Letter